Clinical Study With Lymfactin® in the Treatment of Patients With Secondary Lymphedema (AdeLE)

Summary

This study evaluates the efficacy of Lymfactin® in patients with secondary lymphedema associated with the treatment of breast cancer by comparing the effects of active study treatment Lymfactin® to placebo. The study product will be administered in combination with a surgical lymph node transfer operation. In addition, the safety and tolerability of the Lymfactin® treatment will be evaluated.

Timeline

Start

2018-06-07

Primary completion

2019-12-16

Completion

2024-10-23

Drugs

Indications